Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 439

1.
2.
3.

Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force.

Hayden M, Pignone M, Phillips C, Mulrow C.

Ann Intern Med. 2002 Jan 15;136(2):161-72.

PMID:
11790072
4.

Update on aspirin in the treatment and prevention of cardiovascular disease.

Hennekens CH.

Am J Manag Care. 2002 Dec;8(22 Suppl):S691-700. Review.

5.

Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.

Sutcliffe P, Connock M, Gurung T, Freeman K, Johnson S, Kandala NB, Grove A, Gurung B, Morrow S, Clarke A.

Health Technol Assess. 2013 Sep;17(43):1-253. doi: 10.3310/hta17430. Review.

6.

Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials.

Helton TJ, Bavry AA, Kumbhani DJ, Duggal S, Roukoz H, Bhatt DL.

Am J Cardiovasc Drugs. 2007;7(4):289-97.

PMID:
17696569
7.

Antiplatelet agents and anticoagulants for hypertension.

Lip GY, Felmeden DC, Dwivedi G.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD003186. doi: 10.1002/14651858.CD003186.pub3. Review.

PMID:
22161375
8.

Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.

Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL.

JAMA. 2006 Jan 18;295(3):306-13. Erratum in: JAMA. 2006 May 3;295(17):2002.

PMID:
16418466
9.

Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease.

Keller TT, Squizzato A, Middeldorp S.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005158. Review. Update in: Cochrane Database Syst Rev. 2011;(1):CD005158.

PMID:
17636787
10.

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE.

N Engl J Med. 2005 Mar 31;352(13):1293-304. Epub 2005 Mar 7.

12.

Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease.

Squizzato A, Keller T, Romualdi E, Middeldorp S.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD005158. doi: 10.1002/14651858.CD005158.pub3. Review.

PMID:
21249668
13.

Aspirin for primary prevention: yes or no?

Selak V, Elley CR, Wells S, Rodgers A, Sharpe N.

J Prim Health Care. 2010 Jun;2(2):92-9.

PMID:
20690297
14.

Aspirin and primary cardiovascular prevention. Uncertain balance between benefits and risks.

[No authors listed]

Prescrire Int. 2010 Nov;19(110):258-61. Review.

PMID:
21284360
15.

Aspirin for primary prevention of cardiovascular disease events.

Nemerovski CW, Salinitri FD, Morbitzer KA, Moser LR.

Pharmacotherapy. 2012 Nov;32(11):1020-35. doi: 10.1002/phar.1127. Epub 2012 Sep 27. Review.

PMID:
23019080
16.

The aspirin controversy in primary prevention.

Raju NC, Eikelboom JW.

Curr Opin Cardiol. 2012 Sep;27(5):499-507. doi: 10.1097/HCO.0b013e328356ae95. Review.

PMID:
22874127
17.

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

Antithrombotic Trialists' (ATT) Collaboration., Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A.

Lancet. 2009 May 30;373(9678):1849-60. doi: 10.1016/S0140-6736(09)60503-1.

19.

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Antithrombotic Trialists' Collaboration..

BMJ. 2002 Jan 12;324(7329):71-86. Erratum in: BMJ 2002 Jan 19;324(7330):141.

20.

Antiplatelet agents and anticoagulants for hypertension.

Lip GY, Felmeden DC.

Cochrane Database Syst Rev. 2004;(3):CD003186. Review. Update in: Cochrane Database Syst Rev. 2011;(12):CD003186.

PMID:
15266473

Supplemental Content

Support Center